The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer. Binder PS, Hashim YM, Cripe J, Buchanan T, et al. BMC Cancer 2022;22:263.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Binder PS, Hashim YM, Cripe J, Buchanan T, et al. The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer. BMC Cancer 2022;22:263.
PMID: 35279106